Alzheimer's disease is likely caused by stalled protein processing in the brain, according to a new study.

Recent studies implicate the immune system and a herpes virus as potential contributors to development of disease ...

A common cognitive disorder with symptoms that mimic Alzheimer's is often mistaken for the disease. Researchers are calling for criteria to diagnose the little-known condition.

Innovative Research Combines Ayurvedic Medicine and Chemically Designed Peptides to Combat Amyloid Aggregation in ...

Xenon gas, currently used in medicine as an anesthetic and neuroprotective agent for treating brain injuries, showed potential in protecting the brain in studies.

Late-onset Alzheimer's disease is a debilitating, progressive neurodegenerative disease that affects about 7 million ...

The gas xenon, like the other noble, or inert, gases, is known for doing very little. The class of elements, because of its ...

There is a potential link between Alzheimer's disease and the herpes simplex virus-1 (HSV-1), which is a common cause for ...

This study offers hope for a new approach to treating Alzheimer's disease. The US Food and ... s has been concentrated on targeting beta-amyloid plaques that build up in the brain.

A new study published in the Journal of Neurosurgery highlights the potential of focused ultrasound technology in treating ...

Global Alzheimer's Disease Therapeutics Market Size is expected to be worth around USD 30.8 Billion by 2033 from USD 5.5 Billion in 2023.